Grant of Options
LONDON, U.K AND DALLAS, TX, U.S. – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that it has granted options (“Options”) over a total of 1,080,000 common stock of US$0.001 (“Common Stock”) in the Company (“Shares”) to various new employees of the Company in accordance with the Company’s 2018 Long Term Incentive Plan. The Options vest over a three-year period from the date of grant, expire after ten years and have an exercise price of 35.5 pence.
| Spectral MD Holdings, Ltd. | investors.spectralmd.com |
| Wensheng Fan, Chief Executive Officer | via Walbrook PR |
| Nils Windler, Chief Financial Officer | |
| SP Angel Corporate Finance LLP (NOMAD and Joint Broker) Stuart Gledhill/Caroline Rowe (Corporate Finance)Vadim Alexandre/Rob Rees (Sales & Broking) |
Tel: +44 (0)20 3470 0470 |
| Stifel Nicolaus Europe Limited (Joint Broker)Charles Hoare / Ben Maddison / Nick Harland /Will Palmer-Brown | Tel: +44 (0)20 7710 7600 |
| Walbrook PR Ltd (Media & Investor Relations) | Tel: +44 (0)20 7933 8780 or spectralMD@walbrookpr.com |
| Paul McManus / Louis Ashe-Jepson Alice Woodings |
Mob: +44 (0)7980 541 893 / +44 (0)7747 515 393 +44 (0)7407 804 654 |
About Spectral MD:
We are a dedicated team of forward-thinkers striving to revolutionize the management of wound care by “Seeing the Unknown” ® with our DeepView® Wound Imaging System.